- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: HR /HER2- advanced or metastatic breast cancer
Total 256946 results
-
University of Milano BicoccaRecruitingAdvanced Breast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerItaly
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
Hunan Cancer HospitalRecruiting
-
Daiichi SankyoCompletedHER2-positive Breast CancerSpain, Ireland, Italy
-
Henan Cancer HospitalUnknown
-
Universitair Ziekenhuis BrusselRecruitingCarcinoma | Receptor, ErbB-2Belgium
-
Memorial Sloan Kettering Cancer CenterCompletedBreast CancerUnited States
-
Cancer Trials IrelandCompletedMetastatic Breast CancerSpain, Ireland, Israel, Finland, Portugal, France, Germany, Norway
-
Istituto Oncologico Veneto IRCCSUniversity of PadovaCompleted
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownHER2-positive Metastatic Breast CancerChina
-
Galena Biopharma, Inc.CompletedBreast Cancer With Low to Intermediate HER2 ExpressionUnited States, United Kingdom, France, Israel, Germany, Canada, Russian Federation, Romania, Bulgaria, Czech Republic, Hungary, Poland, Ukraine
-
Black Diamond Therapeutics, Inc.TerminatedSolid TumorUnited States, Denmark, France, Spain
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingNon-squamous NSCLC | HER2 Exon 20 MutationKorea, Republic of, United States, Taiwan, Belgium, Spain, China, Australia, Turkey, Italy, France, Germany, Poland, Russian Federation
-
Nuvation Bio Inc.WithdrawnBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Cancer of Breast | Malignant Tumor of Breast | Breast Tumor | Cancer of the BreastUnited States
-
Eli Lilly and CompanyWithdrawnMetastatic Breast CancerUnited States, Taiwan, Italy, Austria, Germany, Puerto Rico, Belgium, Argentina, Brazil
-
N.N. Petrov National Medical Research Center of...RecruitingOligometastatic Disease | HER2-positive Metastatic Breast CancerRussian Federation
-
Bristol-Myers SquibbCompletedBreast Cancer | MetastasisUnited States, Spain, Belgium, Peru, Italy, Argentina, France
-
RemeGen Co., Ltd.CompletedGastric Cancer | HER2 Overexpressing Gastric CarcinomaChina
-
National Cancer Institute (NCI)TerminatedMalignant Neoplasm | Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder Cancer | Adenocarcinoma of the Gallbladder | Adenocarcinoma of the Extrahepatic Bile DuctUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingHER2/Neu Negative | Estrogen Receptor-positive Breast Cancer | Stage IV Breast Cancer AJCC v6 and v7United States
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingUrothelial CarcinomaUnited States, Canada, United Kingdom, Japan, Australia, Argentina, Chile, Israel
-
The First Affiliated Hospital with Nanjing Medical...Anhui Provincial Cancer Hospital; Affiliated Hospital of Jiangnan University; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School and other collaboratorsRecruiting
-
Dana-Farber Cancer InstitutePuma Biotechnology, Inc.; Translational Breast Cancer Research ConsortiumActive, not recruiting
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.Terminated
-
Henan Cancer HospitalNot yet recruitingBreast Cancer | HER2-positive Breast CancerChina
-
AstraZenecaRecruitingBreast Cancer | Breast Neoplasms | Breast Carcinoma | Genes | HER2Kuwait, Saudi Arabia, United Arab Emirates, Qatar
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingHER2 Positive Breast CancerUnited States, Taiwan, Canada, Korea, Republic of, Austria, China, Spain, Japan, France, Italy, Switzerland, Australia, Belgium, Brazil, Germany, Portugal, United Kingdom, Netherlands, Czechia, Greece, Chile, Finland, Poland
-
Daiichi Sankyo, Inc.Completed
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.UnknownBreast Cancer | HER2 Positive | Combination ChemotherapyChina
-
SCRI Development Innovations, LLCEisai Inc.CompletedHER2 Negative Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedSquamous Cell Carcinoma of Head and Neck | Esophageal Squamous Cell Carcinoma | HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma | HER2 + Breast Cancer | HER2 + Gastric CancerTaiwan, Spain, Canada, Korea, Republic of, United States
-
Cancer Trials IrelandCompletedBreast Cancer | HER2 Positive Breast Cancer | HER2 Negative Breast CancerIreland
-
MacroGenicsApproved for marketingHER2-positive Breast Cancer | HER2-positive Carcinoma
-
Beijing 302 HospitalNot yet recruitingHR+/HER2- Advanced Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterHoffmann-La Roche; Genentech, Inc.; Hartford HealthCareActive, not recruitingMetastatic HER2-Positive Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUnited States Department of DefenseActive, not recruitingBreast Cancer | Metastatic HER2-negative BreastUnited States
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHER2 Positive Metastatic Breast CancerChina
-
Seagen Inc.CompletedHER2 Positive Metastatic Breast CancersUnited States
-
Gilead SciencesTerminatedAdvanced Estrogen Receptor Positive HER2- Breast CancerUnited States
-
German Breast GroupBoehringer IngelheimCompleted
-
AstraZenecaRecruitingER+ HER2- Advanced Breast Cancer | High-grade Serous Ovarian Cancer (HGSOC)United Kingdom, Korea, Republic of, Australia, United States, Spain
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingStage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
AstraZenecaRecruitingLocally Advanced (Inoperable) or Metastatic Breast CancerSpain, Denmark, United States, Korea, Republic of, Germany, Belgium, Vietnam, United Kingdom, France, Japan, Brazil, Canada, China, India, Malaysia, Taiwan, Thailand, Australia, Turkey, Argentina, Poland, Sweden, Italy
-
National Taiwan University HospitalMerck Sharp & Dohme LLCTerminatedPremenopausal Breast CancerTaiwan
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Not yet recruitingMetastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IV Colon Cancer AJCC v8 | Stage IV Colorectal Cancer AJCC v8 | Stage IV Rectal Cancer AJCC v8United States
-
Accutar Biotechnology IncTerminatedBreast CancerUnited States
-
Seagen Inc.Merck Sharp & Dohme LLC; RemeGen Co., Ltd.RecruitingUrothelial CarcinomaUnited States, Canada, Australia, Singapore
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer MetastaticChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruiting